000788 北大医药
已收盘 07-11 15:00:00
资讯
新帖
简况
北大医药最新公告:全资子公司新优势(重庆)拟使用自有资金开展证券投资业务
证券之星 · 07-04
北大医药最新公告:全资子公司新优势(重庆)拟使用自有资金开展证券投资业务
北大医药(000788.SZ)拟出资500万元发起设立公益基金会
智通财经 · 07-04
北大医药(000788.SZ)拟出资500万元发起设立公益基金会
北大医药:子公司3000万元开展证券投资
格隆汇 · 07-04
北大医药:子公司3000万元开展证券投资
小北有料 | 北大医药与健之佳达成战略合作 打造市场新标杆
北大医药 · 06-25
小北有料 | 北大医药与健之佳达成战略合作 打造市场新标杆
北大医药:关于公司董事兼总裁辞职的公告
新浪财经-鹰眼工作室 · 06-24
北大医药:关于公司董事兼总裁辞职的公告
北大医药:公司经营业绩稳步增长且加强现金分红力度与频次
证券之星 · 06-18
北大医药:公司经营业绩稳步增长且加强现金分红力度与频次
北大医药:公司主要从事化学仿制药制剂的研发、生产和销售以及医药流通等业务
证券之星 · 06-17
北大医药:公司主要从事化学仿制药制剂的研发、生产和销售以及医药流通等业务
异动快报:北大医药(000788)6月17日10点35分触及涨停板
证券之星 · 06-17
异动快报:北大医药(000788)6月17日10点35分触及涨停板
异动快报:北大医药(000788)6月16日9点55分触及涨停板
证券之星 · 06-16
异动快报:北大医药(000788)6月16日9点55分触及涨停板
每周股票复盘:北大医药(000788)2024年年度权益分派实施
证券之星 · 06-14
每周股票复盘:北大医药(000788)2024年年度权益分派实施
北大医药:公司于2024年首次增加了半年度现金分红
证券之星 · 06-09
北大医药:公司于2024年首次增加了半年度现金分红
北大医药:公司经营业绩稳步增长,加强现金分红力度与频次
证券之星 · 06-06
北大医药:公司经营业绩稳步增长,加强现金分红力度与频次
北大医药:公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务
证券之星 · 06-04
北大医药:公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务
北大医药:公司经营业绩稳步增长,参见2024年度报告和2025年一季度报告
证券之星 · 05-29
北大医药:公司经营业绩稳步增长,参见2024年度报告和2025年一季度报告
每周股票复盘:北大医药(000788)2024年度股东大会顺利召开,黄联军补选为非独立董事
证券之星 · 05-24
每周股票复盘:北大医药(000788)2024年度股东大会顺利召开,黄联军补选为非独立董事
北大医药:努力成为领先的原料制剂一体化医药科技企业
证券之星 · 05-21
北大医药:努力成为领先的原料制剂一体化医药科技企业
北大医药:公司董事变更程序符合相关法律法规规定
证券之星 · 05-13
北大医药:公司董事变更程序符合相关法律法规规定
北大医药(000788)4月30日股东户数5.39万户,较上期增加6.51%
证券之星 · 05-12
北大医药(000788)4月30日股东户数5.39万户,较上期增加6.51%
北大医药:公司严格按照相关法律法规要求对重大事项和定期报告等及时履行信息披露义务
证券之星 · 04-28
北大医药:公司严格按照相关法律法规要求对重大事项和定期报告等及时履行信息披露义务
图解北大医药年报:第四季度单季净利润同比增525.55%
证券之星 · 04-24
图解北大医药年报:第四季度单季净利润同比增525.55%
加载更多
公司概况
公司名称:
北大医药股份有限公司
所属行业:
医药制造业
上市日期:
1997-06-16
主营业务:
北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、奥氮平片盐酸丁螺环酮片、右酮洛芬胶囊右酮洛芬片、塞来昔布胶囊、奥氮平片。北大医药拥有50余年医药制造历史,是国家创新型试点企业,国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业。
发行价格:
5.70
{"stockData":{"symbol":"000788","market":"SZ","secType":"STK","nameCN":"北大医药","latestPrice":6.49,"timestamp":1752217425000,"preClose":6.51,"halted":0,"volume":17176600,"delay":0,"changeRate":-0.0031,"floatShares":596000000,"shares":596000000,"eps":0.2343,"marketStatus":"已收盘","change":-0.02,"latestTime":"07-11 15:00:00","open":6.5,"high":6.57,"low":6.43,"amount":112000000,"amplitude":0.0215,"askPrice":6.5,"askSize":1368,"bidPrice":6.49,"bidSize":1151,"shortable":0,"etf":0,"ttmEps":0.2343,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.51,"symbolType":"stock","openAndCloseTimeList":[[1752197400000,1752204600000],[1752210000000,1752217200000]],"highLimit":7.16,"lowLimit":5.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":595987425,"isCdr":false,"pbRate":2.49,"roa":"--","peRate":27.699531,"roe":"2.97%","epsLYR":0.2315,"committee":-0.211962,"marketValue":3868000000,"turnoverRate":0.0288,"status":1,"floatMarketCap":3868000000},"requestUrl":"/m/hq/s/000788","defaultTab":"news","newsList":[{"id":"2548236103","title":"北大医药最新公告:全资子公司新优势(重庆)拟使用自有资金开展证券投资业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2548236103","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548236103?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:11","pubTimestamp":1751620267,"startTime":"0","endTime":"0","summary":"北大医药(000788.SZ)公告称,公司全资子公司新优势(重庆)健康产业发展有限公司拟运用自有资金,使用独立的自营账户,开展场内股票、债券投资,投资总额度不超过公司最近一期经审计净资产的10%。投资目的是积极响应“活跃资本市场,提振投资者信心”的工作规划,探索丰富的盈利和投资模式,推动企业经营质量与资本价值的良性互动。证券投资存在宏观经济、行业周期、财政及货币政策等多种因素影响,以及相关工作人员的操作风险,收益具有不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400027094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","000788","BK0060","BK0012","BK0096","BK0028","161027","BK0239","BK0122"],"gpt_icon":0},{"id":"2548369049","title":"北大医药(000788.SZ)拟出资500万元发起设立公益基金会","url":"https://stock-news.laohu8.com/highlight/detail?id=2548369049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548369049?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:04","pubTimestamp":1751619867,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北大医药(000788.SZ)发布公告,公司秉持可持续发展理念,积极支持公益慈善事业。公司为响应国家“健康中国2030”战略,弥补医疗健康领域公益资源缺口,整合医疗健康行业(药企、医疗机构、科研单位等)资源,推动普惠医疗、贫困救助、医药医疗科研创新等,同时也为加强公司公益事业的规划和管理,更好履行作为公众公司的社会责任,持续提升公司品牌的影响力,公司拟出资人民币500万元发起设立公益基金会。公司本次拟捐赠500万元人民币并设立重庆建渝基金会,其核心目标是通过公益慈善推动医疗健康公平,重点覆盖弱势群体(如低收入患者、罕见病患者、偏远地区医疗援助等)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","000788","BK0102","BK0012","BK0060","BK0096","BK0122","BK0028"],"gpt_icon":0},{"id":"2548694463","title":"北大医药:子公司3000万元开展证券投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2548694463","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548694463?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:03","pubTimestamp":1751619803,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0096","UCmain","CNHmain","BK0012","000788","BK0028","BK0122","BK0060","BK0102","BK0239","MUCmain","161027","MCNHmain","CYB"],"gpt_icon":0},{"id":"2546269817","title":"小北有料 | 北大医药与健之佳达成战略合作 打造市场新标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2546269817","media":"北大医药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546269817?lang=zh_cn&edition=full","pubTime":"2025-06-25 10:48","pubTimestamp":1750819731,"startTime":"0","endTime":"0","summary":"为紧跟药品零售终端日渐增长行业趋势,践行北大医药“双轮驱动”营销战略,加速拓展院外市场,近期,北大医药与云南健之佳达成深度战略合作,以公司抗炎镇痛核心产品右酮洛芬胶囊为切入点,共同探索创新合作模式,开启KA连锁标杆合作新篇章。此次战略携手,是北大医药应对行业变革、探索营销新模式的主动布局,更是践行“以患者为中心”理念的深度实践。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625111841a71c3e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625111841a71c3e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0122","000788","BK0102","BK0060","BK0096","BK0209","BK0028","605266","BK0239"],"gpt_icon":0},{"id":"2545284847","title":"北大医药:关于公司董事兼总裁辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2545284847","media":"新浪财经-鹰眼工作室","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545284847?lang=zh_cn&edition=full","pubTime":"2025-06-24 19:40","pubTimestamp":1750765200,"startTime":"0","endTime":"0","summary":"北大医药股份有限公司关于公司董事兼总裁辞职的公告北大医药股份有限公司董事会于近日收到董事兼总裁袁平东先生的书面辞职报告。袁平东先生因个人原因申请辞去公司董事、总裁职务,同时辞去董事会战略委员会委员职务,且不再担任公司任何职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-06-24/doc-infcerue8901458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0096","BK0060","BK0102","BK0028","BK0122","000788","BK0239","BK0012"],"gpt_icon":0},{"id":"2544439977","title":"北大医药:公司经营业绩稳步增长且加强现金分红力度与频次","url":"https://stock-news.laohu8.com/highlight/detail?id=2544439977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544439977?lang=zh_cn&edition=full","pubTime":"2025-06-18 20:53","pubTimestamp":1750251221,"startTime":"0","endTime":"0","summary":"近年来,公司经营业绩稳步增长,关于公司经营业绩情况可参见公司于2025年4月25日在巨潮资讯网披露的2024年度报告和2025年一季度报告。此外,公司为提高投资者回报,增强投资者信心,还加强了现金分红力度与频次,包括实施了2024年半年度和2024年度现金分红。感谢您对北大医药的关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800035469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","BK0060","BK0096","000788","BK0102","BK0012","BK0028"],"gpt_icon":0},{"id":"2544118956","title":"北大医药:公司主要从事化学仿制药制剂的研发、生产和销售以及医药流通等业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2544118956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544118956?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:00","pubTimestamp":1750147259,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药06月17日在投资者关系平台上答复投资者关心的问题。公司主要从事化学仿制药制剂的研发、生产和销售以及医药流通等业务,未涉及创新药、脑机接口等业务。感谢您对北大医药的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700021771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0012","BK0239","BK0060","BK1515","000788","BK0028","BK0096","BK0102","BK1161","BK1574","09939","159938"],"gpt_icon":0},{"id":"2544093530","title":"异动快报:北大医药(000788)6月17日10点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2544093530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544093530?lang=zh_cn&edition=full","pubTime":"2025-06-17 10:40","pubTimestamp":1750128027,"startTime":"0","endTime":"0","summary":"证券之星6月17日盘中消息,10点35分北大医药触及涨停板。目前价格7.21,上涨10.08%。其所属行业化学制药目前下跌。领涨股为北陆药业。该股为高校系,医药商业,新冠药物概念热股,当日高校系概念上涨0.29%。6月16日的资金流向数据方面,主力资金净流入9542.77万元,占总成交额32.5%,游资资金净流出4246.44万元,占总成交额14.46%,散户资金净流出5296.33万元,占总成交额18.04%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700010512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0102","BK0012","BK0060","BK0122","000788","BK0028"],"gpt_icon":0},{"id":"2543264308","title":"异动快报:北大医药(000788)6月16日9点55分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2543264308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543264308?lang=zh_cn&edition=full","pubTime":"2025-06-16 10:01","pubTimestamp":1750039263,"startTime":"0","endTime":"0","summary":"证券之星6月16日盘中消息,9点55分北大医药触及涨停板。目前价格6.58,上涨10.03%。其所属行业化学制药目前上涨。领涨股为广生堂。该股为医药商业,医药,高校系概念热股,当日医药商业概念上涨0.99%,医药概念上涨0.95%,高校系概念上涨0.91%。6月13日的资金流向数据方面,主力资金净流出644.91万元,占总成交额12.14%,游资资金净流出224.12万元,占总成交额4.22%,散户资金净流入869.03万元,占总成交额16.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600004115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0102","BK0028","BK0122","BK0060","000788","BK0239","BK0096"],"gpt_icon":0},{"id":"2543665256","title":"每周股票复盘:北大医药(000788)2024年年度权益分派实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2543665256","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543665256?lang=zh_cn&edition=full","pubTime":"2025-06-14 11:08","pubTimestamp":1749870493,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘,北大医药报收于5.98元,较上周的5.97元上涨0.17%。本周,北大医药6月10日盘中最高价报6.24元。本周关注点公司公告汇总:北大医药2024年年度权益分派,每10股派发现金0.30元,股权登记日为2025年6月16日。公司公告汇总北大医药发布2024年年度权益分派实施公告,宣布将以2024年12月31日的总股本595,987,425股为基数,向全体股东每10股派发现金0.30元(含税),总计派发红利17,879,622.75元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400011404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0012","BK0060","BK0096","BK0239","000788","BK0102","BK0028"],"gpt_icon":0},{"id":"2542805405","title":"北大医药:公司于2024年首次增加了半年度现金分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2542805405","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542805405?lang=zh_cn&edition=full","pubTime":"2025-06-09 15:58","pubTimestamp":1749455891,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药(000788)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司对加大投资分红力度好似不是有啥误解,市值一路下跌,一年只是10派0.3,这也算加大分红力度吗北大医药回复:投资者您好!公司近年来经营业绩稳步提升,为提高投资者回报,增强投资者信心,公司加强了现金分红力度与频次。相较于历年现金分红情况,公司于2024年首次增加了半年度现金分红。关于公司现金分红情况请参见公司在巨潮资讯网披露的相关公告,感谢您对北大医药的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900016950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000788","BK0102","BK0012","BK0060","BK0096","BK0122","BK0028"],"gpt_icon":0},{"id":"2541185094","title":"北大医药:公司经营业绩稳步增长,加强现金分红力度与频次","url":"https://stock-news.laohu8.com/highlight/detail?id=2541185094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541185094?lang=zh_cn&edition=full","pubTime":"2025-06-06 20:51","pubTimestamp":1749214295,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药06月05日在投资者关系平台上答复投资者关心的问题。请问公司,变更实控人后,公司是否已经自暴自弃,准备退出医药行业北大医药回复:投资者您好!近年来,公司经营业绩稳步增长,关于公司经营业绩情况可参见公司于2025年4月25日在巨潮资讯网披露的2024年度报告和2025年一季度报告。此外,公司为提高投资者回报,增强投资者信心,还加强了现金分红力度与频次。感谢您对北大医药的关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600039166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000788","BK0012","BK0028","BK0239","BK0060","BK0102","BK0122"],"gpt_icon":0},{"id":"2540066575","title":"北大医药:公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2540066575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540066575?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:51","pubTimestamp":1749041474,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药06月03日在投资者关系平台上答复投资者关心的问题。接管公司,又成立两家无实际业务的子公司,公司市值也一直下跌,如今合作伙伴又终止业务合作。公司主要从事化学药品制剂的研发、生产和销售以及医药流通等业务。近年来,公司经营业绩稳步增长,关于公司经营业绩情况可参见公司于2025年4月25日在巨潮资讯网披露的2024年度报告和2025年一季度报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400036197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0102","000788","BK0122","BK1161","09939","BK1574","BK1515","BK0239","BK0096","159938","BK0060","BK0012"],"gpt_icon":0},{"id":"2539263817","title":"北大医药:公司经营业绩稳步增长,参见2024年度报告和2025年一季度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2539263817","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539263817?lang=zh_cn&edition=full","pubTime":"2025-05-29 20:55","pubTimestamp":1748523330,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药05月28日在投资者关系平台上答复投资者关心的问题。近年来,公司经营业绩稳步增长,关于公司经营业绩情况可参见公司于2025年4月25日在巨潮资讯网披露的2024年度报告和2025年一季度报告。此外,公司为提高投资者回报,增强投资者信心,还加强了现金分红力度与频次。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900035417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","000788","BK0122","BK0060","BK0239","BK0102","BK0028","BK0096"],"gpt_icon":0},{"id":"2537167735","title":"每周股票复盘:北大医药(000788)2024年度股东大会顺利召开,黄联军补选为非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2537167735","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537167735?lang=zh_cn&edition=full","pubTime":"2025-05-24 15:22","pubTimestamp":1748071331,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,北大医药报收于5.86元,较上周的5.81元上涨0.86%。本周,北大医药5月23日盘中最高价报5.96元。本周关注点公司公告汇总:北大医药2024年度股东大会顺利召开,审议通过多项议案。公司公告汇总北大医药股份有限公司2024年度股东大会于2025年5月22日下午14点30分召开,采用现场表决与网络投票相结合的方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400012785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0060","BK0102","BK0122","BK0239","000788","BK0012"],"gpt_icon":0},{"id":"2537933950","title":"北大医药:努力成为领先的原料制剂一体化医药科技企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537933950?lang=zh_cn&edition=full","pubTime":"2025-05-21 20:51","pubTimestamp":1747831886,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药05月20日在投资者关系平台上答复投资者关心的问题。公司不与优秀公司合作,反而与存在劣迹的公司合作,请问公司管理层是怎么考虑的北大医药回复:投资者您好!公司近年来以“努力成为领先的原料制剂一体化医药科技企业”为战略定位,紧密围绕既定发展战略,以“补产品、补产能、补人才、抓市场”为核心经营思路,不断加强公司经营管理,力争推动公司更好发展。感谢您对北大医药的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100037259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159938","BK0012","000788","BK0028","BK0122","BK1515","BK0096","BK0102","BK1161","BK0060","BK0239","09939"],"gpt_icon":0},{"id":"2535251719","title":"北大医药:公司董事变更程序符合相关法律法规规定","url":"https://stock-news.laohu8.com/highlight/detail?id=2535251719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535251719?lang=zh_cn&edition=full","pubTime":"2025-05-13 16:39","pubTimestamp":1747125565,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药05月13日在投资者关系平台上答复投资者关心的问题。请问公司将来是否要弱化医药行业,转为其他行业北大医药回复:投资者您好!公司实控人变更后,新实控人与新方正控股发展有限责任公司、方正商业管理有限责任公司按照签订的《股权转让协议》约定,正常推动公司董事成员变更工作,公司董事变更程序符合相关法律法规规定,感谢您对北大医药的关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300025455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","000788","BK0102","BK0012","BK0122","BK0239","BK0096"],"gpt_icon":0},{"id":"2534101402","title":"北大医药(000788)4月30日股东户数5.39万户,较上期增加6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534101402","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534101402?lang=zh_cn&edition=full","pubTime":"2025-05-12 17:21","pubTimestamp":1747041676,"startTime":"0","endTime":"0","summary":"证券之星消息,近日北大医药披露,截至2025年4月30日公司股东户数为5.39万户,较3月31日增加3294.0户,增幅为6.51%。在化学制药行业个股中,北大医药股东户数高于行业平均水平,截至4月30日,化学制药行业平均股东户数为3.21万户。从股价来看,2025年3月31日至2025年4月30日,北大医药区间跌幅为2.78%,在此期间股东户数增加3294.0户,增幅为6.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051200022665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000788","BK0028","BK0096","BK0102","BK0012","BK0122","BK0060"],"gpt_icon":0},{"id":"2530038446","title":"北大医药:公司严格按照相关法律法规要求对重大事项和定期报告等及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2530038446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530038446?lang=zh_cn&edition=full","pubTime":"2025-04-28 15:03","pubTimestamp":1745823791,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药04月27日在投资者关系平台上答复投资者关心的问题。请公司将真实的营业情况告知投资者北大医药回复:投资者您好!公司严格按照相关法律法规要求对重大事项和定期报告等及时履行信息披露义务。公司2024年年度报告已经会计师事务所审计,并于2025年4月25日披露于巨潮资讯网。感谢您对北大医药的关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042800016849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0060","BK0102","BK0122","BK0239","000788","BK0012"],"gpt_icon":0},{"id":"2530296879","title":"图解北大医药年报:第四季度单季净利润同比增525.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530296879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530296879?lang=zh_cn&edition=full","pubTime":"2025-04-25 01:25","pubTimestamp":1745515548,"startTime":"0","endTime":"0","summary":"证券之星消息,北大医药2024年年报显示,公司主营收入20.6亿元,同比下降6.1%;归母净利润1.38亿元,同比上升211.1%;扣非净利润1.27亿元,同比上升221.05%;其中2024年第四季度,公司单季度主营收入5.26亿元,同比下降2.35%;单季度归母净利润762.76万元,同比上升525.55%;单季度扣非净利润-228.67万元,同比下降273.31%;负债率33.9%,投资收益-23.57万元,财务费用-65.45万元,毛利率26.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500000867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000788"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752445140843,"stockEarnings":[{"period":"1week","weight":0.0015},{"period":"1month","weight":0.0688},{"period":"3month","weight":0.1963},{"period":"6month","weight":0.1145},{"period":"1year","weight":0.2676},{"period":"ytd","weight":0.0866}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.084},{"period":"6month","weight":0.1078},{"period":"1year","weight":0.1817},{"period":"ytd","weight":0.0473}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北大医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48221人(较上一季度减少10.50%)","perCapita":"12359股","listingDate":"1997-06-16","address":"重庆市北碚区水土镇方正大道21号","registeredCapital":"59598万元","survey":" 北大医药股份有限公司的主营业务是化学药品制剂的研发、生产和销售,医药流通以及医疗服务等业务。公司的主要产品是注射用头孢曲松钠、注射用美罗培南、注射用头孢米诺钠、盐酸莫西沙星注射液、盐酸克林霉素棕榈酸酯颗粒、萘丁美酮胶囊、奥氮平片盐酸丁螺环酮片、右酮洛芬胶囊右酮洛芬片、塞来昔布胶囊、奥氮平片。北大医药拥有50余年医药制造历史,是国家创新型试点企业,国家火炬计划重点高新技术企业、国家两化融合贯标示范企业、重庆市技术创新示范企业。","listedPrice":5.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北大医药,000788,北大医药股票,北大医药股票老虎,北大医药股票老虎国际,北大医药行情,北大医药股票行情,北大医药股价,北大医药股市,北大医药股票价格,北大医药股票交易,北大医药股票购买,北大医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北大医药(000788)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北大医药(000788)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}